TickerFacts.

Cytosorbents Corp (CTSO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2014-12-31, 2023-12-31, 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$13.52M
Year ended 2025-12-31
2010-12-31: -$2.81M2011-12-31: -$4.40M2012-12-31: -$3.44M2013-12-31: -$4.65M2014-12-31: -$6.83M2015-12-31: -$9.19M2016-12-31: -$11.33M2017-12-31: -$9.62M2018-12-31: -$15.19M2019-12-31: -$18.39M2020-12-31: -$9.71M2021-12-31: -$22.01M2022-12-31: -$30.64M2023-12-31: -$30.49M2024-12-31: -$15.12M2025-12-31: -$13.52M-$13.52M
2010-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$13.52Mn/m2026-03-30, From 2025-01-01
2024-12-31-$15.12Mn/c2026-03-30, From 2024-01-01
2023-12-31-$30.49Mn/c2025-03-31, From 2023-01-01
2022-12-31-$30.64Mn/m2024-03-15, From 2022-01-01
2021-12-31-$22.01Mn/m2024-03-15, From 2021-01-01
2020-12-31-$9.71Mn/m2023-03-09, From 2020-01-01
2019-12-31-$18.39Mn/m2022-03-10, From 2019-01-01
2018-12-31-$15.19Mn/m2021-03-09, From 2018-01-01
2017-12-31-$9.62Mn/m2020-03-05, From 2017-01-01
2016-12-31-$11.33Mn/m2019-03-07, From 2016-01-01
2015-12-31-$9.19Mn/m2018-03-08, From 2015-01-01
2014-12-31-$6.83Mn/c2017-03-03, From 2014-01-01
2013-12-31-$4.65Mn/m2015-03-31, From 2013-01-01
2012-12-31-$3.44Mn/m2014-03-31, From 2012-01-01
2011-12-31-$4.40Mn/m2013-04-03, From 2011-01-01
2010-12-31-$2.81Mn/a2012-03-30, From 2010-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Cytosorbents Corp (CTSO)2025-12-31-$13.52Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$23.35Mn/m
Retractable Technologies Inc (RVP)2025-12-31-$13.41Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$4.51M-46.4%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.16Mn/m
SS Innovations International, Inc. (SSII)2025-12-31-$7.12Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$5.92M+27.7%

Compare CTSO, CLPT, RVP, IDXG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗